Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

- Acute toxicity Oral: Combined LD50 (rats) = 930 mg/kg bw (OECD 401 / non-GLP / K2) (Bayer, 1982).


- Acute toxicity: Dermal: LD50 (rats) > 5000 mg/kg bw (EU RAR 2003).


- Acute toxicity: Inhalation: no relevant study available.

Key value for chemical safety assessment

Acute toxicity: via oral route

Link to relevant study records
Reference
Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1981
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Comparable to guideline study with acceptable restrictions
Qualifier:
according to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Deviations:
yes
Remarks:
Analytical purity not reported. Acclimation period not reported. Body weights were not reported.
GLP compliance:
no
Remarks:
GLP was not mandatory at the time of the study
Test type:
acute toxic class method
Limit test:
no
Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Winkelmann, Borchen, Germany
- Age at study initiation: 9 (males) - 14 (females) weeks
- Weight at study initiation: 159-173 g (males); 159-172 g (females)
- Fasting period before study: the animals were fasted from 16 to 4 hours before the dosing
- Housing: Rats were housed in number of 5 per cage in Makrolon cages type III
- Diet (e.g. ad libitum): Altromin R 1324, Altromin GmbH, Lage, Germany
- Water (e.g. ad libitum): tap water ad libitum

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 1.5 °C
- Humidity (%): 60 ± 5%
- Photoperiod (hrs dark / hrs light): 12 hrs dark/ 12 hrs light (7am/7pm)



IN-LIFE DATES: From: April To: July 1981
Route of administration:
oral: gavage
Vehicle:
other: cremophore/tap water mixture (1 : 4)
Details on oral exposure:
MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg
Doses:
630-3100 mg/kg
No. of animals per sex per dose:
5
Control animals:
other: not applicable
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: twice per day and once on weekends and holidays. The animals were weighed at the moment of the exposure, after 1 week, and at the end of the 14-day oberservation period.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, gross pathology analysis
Statistics:
The calculation of the LD50 with the confidence interval for p <0.05 was performed with the Probit analysis according to Fink und Hund (Arzneim.-Forsch. 15:1965, 624)
Sex:
male/female
Dose descriptor:
LD50
Effect level:
930 mg/kg bw
95% CL:
>= 840 - <= 1 050
Remarks on result:
other: Slope=9.11
Mortality:
The deaths occurred during the first 3 days of the treatment
Clinical signs:
other: See remark
Body weight:
other body weight observations
Remarks:
body weight was not reported
Gross pathology:
In the section of deceased male and female animals were noted alterations of the stomach and intestine mucous membrane, and gastric bleeding .
The liver had a localized clay colour and showed clear lobe markings. At the end of the test in the dissected male and female animals dosed with 1.0 and 1.25 mg/kg were observed slight alterations of the stomach. All other animals were examined macroscopically unremarkable.

Male

Dose

mg/kg

Number of dead animals

Animals with symptoms

Total number of animals employed

Time of death

630

0

0

5

 

730

1

5

5

2ndday

800

3

5

5

2nd-3rdday

1000

3

5

5

2ndday

1250

5

5

5

24 hours-2ndday

1600

5

5

5

24 hours

3100

5

5

5

24 hours

Female

Dose

mg/kg

Number of dead animals

Animals with symptoms

Total number of animals employed

Time of death

630

0

0

5

 

730

0

5

5

 

800

2

5

5

3rdday

1000

3

5

5

2nd-3rdday

1250

3

5

5

24 hours-2ndday

1600

5

5

5

24 hours-2ndday

3100

5

5

5

24 hours

 

Interpretation of results:
Category 4 based on GHS criteria
Executive summary:

Groups of 5 rats of each sex with starting weights between 159 g and 173 g were given 1,2,4-trichlorobenzene (630-3100 mg/kg) by gavage according to OECD guideline 401 with deviations (Analytical purity not reported. Air changes not reported. Acclimation period not reported.Body weights not reported).


The LD50 was 930 mg/kg with 95% confidential limit of 840-1050.


The deaths occurred during the first 3 days of the treatment.


The oral single doses from 730 to 3100 mg/kg provoked the following poisoning symptoms: worsening of the general conditions, sedation, necrosis, side-prone position.


In the section of deceased male and female animals were noted alterations of the stomach and intestine mucous membrane, and gastric bleeding.


The liver had a localized clay colour and showed clear lobe markings. At the end of the test in the dissected male and female animals dosed with 1000 and 1250 mg/kg were observed slight alterations of the stomach. All other animals were examined macroscopically unremarkable.


On the basis of theses findings it is possible to classify 1,2,4 -trichlorobenzene in Category 4 (Acute Tox. 4, H302 according to GHS.


 

Endpoint conclusion
Endpoint conclusion:
adverse effect observed
Dose descriptor:
LD50
Value:
930
Quality of whole database:
One key study available (Bayer, 1982), comparable to guideline study. Other available data report similar LD50, all within the CLP Category 4 range.

Acute toxicity: via inhalation route

Endpoint conclusion
Endpoint conclusion:
no study available

Acute toxicity: via dermal route

Link to relevant study records
Reference
Endpoint:
acute toxicity: dermal
Type of information:
other: EU Risk Assessment
Adequacy of study:
other information
Reliability:
other: EU Risk Assessment
Rationale for reliability incl. deficiencies:
other: no reliability is given as this is a summary entry for the EU RAR
Principles of method if other than guideline:
EU Risk Assessment
GLP compliance:
not specified

EU Risk Assessment (2003):

Some studies on acute dermal toxicity are summarized in EU Risk Assessment.

Some of these studies were reliable studies with restrictions or reliability was not assignable because references were only cited as secondary literature.

Four rats of each sex were exposed for 24 hours with undiluted 98% pure 1,2,4-TCB in an occlusive bandage on the dorso-lumbar region. An LD50 of 6,139 mg 1,2,4-TCB/kg (4299-9056 mg/kg, 95% confidence limits) was estimated. The signs of intoxication were depression of activity at low doses and pre-death extensor convulsions at lethal dose levels. All deaths occurred within 5 days of exposure. Autopsies of the animals that died and those killed after the 10-day observation period revealed no pathological lesions attributable to the compound (Brown et al., 1969).

The acute dermal LD50 in rabbits for pure 1,2,4-TCB is approximately 5,000 mg/kg (Dow

Chemical, 1982) and >5,000 mg/kg for technical 1,2,4-TCB (Dow Chemical, 1980).

A study in ddY mice using 10 animals of each sex per group reporting the acute dermal toxicity gave values of 300 mg/kg (243-369 mg/kg, 95% confidence limits) for males and 305 mg/kg (247-375 mg/kg, 95% confidence limits) for females (Yamamoto et al., 1978). There is no obvious explanation for the very low value for the LD50 found in this study.
Endpoint conclusion
Endpoint conclusion:
no adverse effect observed
Dose descriptor:
LD50
Value:
>= 5 000 mg/kg bw
Quality of whole database:
No key study identified, but the rabbit study reported in the EU RAR showed a LD50 > 5000 mg/kg bw.

Additional information

Acute toxicity: Oral


A key study was identified (Bayer, 1982). In this study performed according to OECD TG 401, the rat (combined) LD50 was 930 mg/kg bw with 95% confidential limit of 840-1050 mg/kg bw. The oral single doses from 730 to 3100 mg/kg bw provoked the following poisoning symptoms: worsening of the general conditions, sedation, necrosis, side-prone position.The deaths occurred during the first 3 days of the treatment. In the section of deceased male and female animals noted alterations were of the stomach and intestine mucous membrane, and gastric bleeding. The liver had a localized clay colour and showed clear lobe markings. At the end of the test in the dissected male and female animals dosed with 1000 and 1250 mg/kg were observed slight alterations of the stomach. All other animals were examined macroscopically unremarkable.


 In the EU RAR, rats LD50 ranging between 880 and 1421 mg/kg bw/day were reported.


 


Acute Toxicity: Dermal


In the EU RAR, rabbits LD50 was reported to be > 5000 mg/kg bw.


 


Acute Toxicity: Inhalation


In the EU RAR, no mortality was reported at concentration of 3.1 mg/L/4hr. As no higher concentration was tested it was not possible to determine a LC50.

Justification for classification or non-classification

Harmonised classification:


The substance is classified as Harmful if swallowed (H302) according to the Regulation (EC) No. 1272/2008 (CLP 000)


The substance has no harmonised classification for acute toxicity via dermal route or inhalation according to the CLP. 


 


Self classification:


Acute toxicity via Oral route:


Based on the available information, the substance is classified in Category 4 according to the CLP and to the GHS as the LD50 is in the range 300-2000 mg/kg bw.


Acute toxicity via Dermal route: 


Based on the available information, the test item is not classified according to the CLP and the GHS as the LD50 is greater than 5000 mg/kg bw 


Acute toxicity via Inhalation:


No study is available. 


Specific target organ toxicity: single exposure (Oral):


The classification criteria according to the CLP and to the GHS as specific target organ toxicant (STOT) – single exposure, oral are not met since no reversible or irreversible adverse health effects were observed immediately or delayed after exposure and no effects were observed at the guidance value (oral) for a Category 1 classification (C≤ 300 mg/kg bw) and at the guidance value (oral) for a Category 2 classification (2000 mg/kg bw≥C > 300 mg/kg bw). No classification is required. 


The criteria for Transient Organ effects (STOT-SE Category 3) according to the CLP and to the GHS are not met since narcotic effects were not observed in the acute oral toxicity study. 


Specific target organ toxicity: single exposure (Dermal):


The classification criteria according to the CLP and the GHS as specific target organ toxicant (STOT) – single exposure, dermal are not met since no reversible or irreversible adverse health effects were observed immediately or delayed after exposure and no effects were observed at the guidance value (dermal) for a Category 1 classification (C ≤ 1000 mg/kg bw) and at the guidance value (dermal) for a Category 2 classification (2000 mg/kg bw ≥ C > 1000 mg/kg bw). No classification is required. 


The criteria for Transient Organ effects (STOT-SE Category 3) according to the CLP and to the GHS are not met since narcotic effects were not observed in the acute dermal toxicity study. 


Specific target organ toxicity: single exposure (Inhalation):


No study is available. 


Aspiration hazard:


The substance is not a hydrocarbon and no effects were observed on lungs in oral studies, therefore the criteria for aspiration toxicity according to the CLP and to the GHS are not met.